Replies to post #1981 on InspireMD Inc (NSPR)

[jarubr]

I think that the important date will be Saturday, November 17th, "Results of A Multicenter Italian Registry Of Real World CAS With The C-Guard Mesh Covered Stent: The IRONGUARD 2 Study"

Jim Barry (CEO NSPR) said on Earnings Call "Additionally, we look forward to the presentation of additional three-year data at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons also referred to as a VEITH Conference in New York later this month, where this data will be presented to vascular surgeons from all over the world and who represent the majority of attendees at this major Vascular Surgery Conference."